首页> 外文期刊>Hepatitis Monthly >Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan
【24h】

Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan

机译:巴基斯坦自身免疫性肝炎的临床概况和HLA分型

获取原文
       

摘要

Background: Human leukocyte antigen (HLA) typing in autoimmune hepatitis (AIH) has been investigated in different populations and ethnic groups, but no such data is available from Pakistan. Objectives: The aim of this study was to evaluate the clinical profile of autoimmune hepatitis (AIH), and determine the associated antigens and alleles by performing HLA typing. Patients and Methods: A total of 58 patients, diagnosed and treated as AIH in the last 10 years were reviewed. Diagnosis was based on International AIH Group criteria. Forty one patients underwent liver biopsy. HLA typing was performed in 44 patients and 912 controls by serological method for HLA A and B, and by PCR technique using sequence specific primers for DR alleles. Results: Of 58 cases, 35 were females (60.3%). The median age was 14.5 (range 4-70 years), and AIH score was 14 (10-22). Thirty-six (62.0%) patients had type 1 AIH, 10 (17.2%) type 2, and the remaining 12 were seronegative with biopsy proven AIH. Forty-nine patients (84.4%) had cirrhosis. Twenty-four (41.4%) patients had ascites at the time of presentation. Among 41 patients who underwent liver biopsy, thirty-two had advance stages III and IV disease, and twenty had severe grade of inflammation. Fifteen patients had other associated autoimmune diseases and one developed hepatocellular carcinoma. HLA A2 (P = 0.036), HLA A9 (23) (P = 0.018), HLA A10 (25) (P = 0.000), HLA A19 (33) (P = 0.000), HLA B15 (63) (P = 0.007), HLA B40 (61) ( P = 0.002), HLA DR6 (P = 0.001) with its subtypes HLA-DRB1*13 (P = 0.032) and HLA-DRB1*14 (p = 0.017) were more prevalent in AIH with statistical significance than controls. Conclusions: AIH in our region presents with advanced disease affecting predominantly children and adolescents. There is a genetic association of HLA DR6 along with other alleles and antigens in our patients with AIH.
机译:背景:已经在不同人群和种族中调查了人类自身免疫性肝炎(AIH)中人白细胞抗原(HLA)的分型,但巴基斯坦没有此类数据。目的:本研究旨在评估自身免疫性肝炎(AIH)的临床概况,并通过进行HLA分型来确定相关抗原和等位基因。患者和方法:回顾了过去10年中诊断并治疗为AIH的58例患者。诊断基于国际AIH集团的标准。 41例患者接受了肝活检。通过针对HLA A和B的血清学方法,以及针对DR等位基因的序列特异性引物的PCR技术,对44例患者和912个对照进行HLA分型。结果:58例中,女性35例(60.3%)。中位年龄为14.5岁(范围为4-70岁),AIH得分为14岁(10-22岁)。三十六名(62.0%)患者患有1型AIH,10名(17.2%)2型患者,其余12例经活检证实为AIH血清阴性。四十九名患者(84.4%)患有肝硬化。报告时有二十四名患者(41.4%)出现腹水。在接受肝活检的41例患者中,有32例处于III和IV期晚期疾病,而20例患有严重的炎症。 15例患有其他相关的自身免疫性疾病,其中1例发展为肝细胞癌。 HLA A2(P = 0.036),HLA A9(23)(P = 0.018),HLA A10(25)(P = 0.000),HLA A19(33)(P = 0.000),HLA B15(63)(P = 0.007) ),HLA B40(61)(P = 0.002),HLA DR6(P = 0.001)及其亚型HLA-DRB1 * 13(P = 0.032)和HLA-DRB1 * 14(p = 0.017)在AIH中更为普遍统计显着性优于对照组。结论:我们地区的AIH呈晚期疾病,主要影响儿童和青少年。在我们的AIH患者中,HLA DR6与其他等位基因和抗原存在遗传关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号